GE HealthCare Names William Grogan as Permanent CFO, Succeeding Interim
GEHC sits 24% above its 52-week low of $58.75.
Summary
GE HealthCare appointed William K. Grogan as permanent CFO effective September 14, 2026, with a compensation package including $4M sign-on equity and $550K cash sign-on.
Key Events · Executive and Board Changes · GEHC
-
Permanent CFO Appointed
William K. Grogan appointed CFO effective September 14, 2026, succeeding interim CFO George Newcomb, who returns to Controller and Chief Accounting Officer.
-
Compensation Package
Grogan's package: $900,000 base salary, 100% target bonus, $3.3M annual LTI, $4M sign-on equity (RSUs vesting over 2 years), and $550,000 cash sign-on.
-
Leadership Transition
Grogan joins from Xylem Inc., where he was CFO since 2023; previously CFO of IDEX Corporation from 2017 to 2023.
-
Interim CFO Returns to Prior Role
George Newcomb, who served as interim CFO since July 2026, will continue as Controller and Chief Accounting Officer.
Analysis · GEHC · Industrial Applications And Services
GE HealthCare appointed William K. Grogan as permanent CFO effective September 14, 2026, filling the vacancy left by Jay Saccaro's departure announced in July. Grogan brings CFO experience from Xylem and IDEX, and his compensation package includes a $4 million sign-on equity award and $550,000 cash sign-on to offset forfeited compensation. This resolves the interim leadership uncertainty and signals a commitment to financial stability.
How filings like this one have moved
In the 30 days to Aug 22, 2026, 29.1% of the 2960 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.01%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, GEHC was trading at $72.85 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $32.7B. The 52-week trading range was $58.75 to $89.77. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.